StockTipsArenaBeta

Akums Drugs and Pharmaceuticals Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹680.2-13.85 (-2.00%)
As of 22 Oct 2026

Avg 1-year target

All 3 long-term calls are BUY

₹84524.2% above today's price

Akums Drugs and Pharmaceuticals' average 1-year share price target is ₹845, the average of 2 advisors' latest targets. Targets range from ₹840 to ₹850.

Latest: Citigroup ₹840 · 18 Aug 2026

3
3 BUY · 0 SELL, all horizons
2
with an active 1Y target
64%
7 of 11 closed calls hit
14
all horizons, open and closed
Watch AKUMS for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Akums Drugs and Pharmaceuticals target price by brokerage

Each advisor's latest 1-year target · 2 advisors · tap a row for the call

All tips (14)

BUYTarget₹840
CbyCitigroup+23.5% to target
1 Year* · 10 mo left · 18 Aug 2026 · entry ₹750 · via CNBC Awaaz.P&L -9.3%
BUYTarget₹860
CbyCitigroup+26.4% to target
1 Year* · 10 mo left · 18 Aug 2026 · entry ₹753.85 · via Zee Business (Live)P&L -9.8%
BUYTarget₹850
ISbyICICI Securities+25.0% to target
1 Year* · 10 mo left · 11 Aug 2026 · entry ₹760.95 · via Institutional / Brokerage ResearchP&L -10.6%
BUYTarget₹680
ISbyICICI SecuritiesTarget hit
1 Year* · 17 Feb 2026 · entry ₹489.95 · via Institutional / Brokerage Researchexit ₹680
BUYTarget₹600
ISbyICICI SecuritiesTarget hit
1 Year* · 22 Dec 2025 · entry ₹443.15 · via Institutional / Brokerage Researchexit ₹600
BUYTarget₹565
ISbyICICI SecuritiesTarget hit
1 Year* · 15 Nov 2025 · entry ₹424.3 · via Institutional / Brokerage Researchexit ₹565
BUYTarget₹655
ISbyICICI SecuritiesTarget hit
1 Year* · 11 Aug 2025 · entry ₹479.65 · via Institutional / Brokerage Researchexit ₹655
BUYTarget₹710
ISbyICICI SecuritiesExpired
1 Year* · 9 Feb 2025 · entry ₹560.9 · via Institutional / Brokerage Researchexit ₹467.2
BUYTarget₹650
AJbyAastha Jain, Hem SecuritiesTarget hit
1–3 Months · 11 Jun 2026 · entry ₹598 · via Zee Business (Live)exit ₹650
BUYTarget₹795
KBbyKush BohraTarget hit
1–2 Weeks* · 19 Aug 2026 · entry ₹746 · via NDTV Profit (Live)exit ₹795
BUYTarget₹735
AJbyAnsh Jogendra BhilwarTarget hit
1–2 Weeks* · 10 Aug 2026 · entry ₹710.1 · via Zee Business (Live)exit ₹735
BUYTarget₹860
AJbyAnand James, Geojit InvestmentsStop-loss hit
1–2 Weeks* · 22 Sept 2026 · entry ₹821 · via Business Standard Marketsexit ₹803
BUYTarget₹830
AKbyAshish Kyal, Waves Strategy AdvisorsStop-loss hit
1–2 Weeks* · 15 Sept 2026 · entry ₹784.2 · via CNBC Awaaz.exit ₹760
BUYTarget₹865
SBbySumeet Bagadia, Choice BrokingExpired
1–2 Weeks* · 15 Sept 2026 · entry ₹776 · via LiveMint Buy-or-Sell (topic)exit ₹800

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks